Researchers have shown that an inflammation-promoting molecule called interleukin-6 (IL-6), which is secreted by astrocytes, may contribute to defects associated with bipolar disorder. The results highlight the potential role of astrocyte-mediated inflammatory signaling in the psychiatric disease, although further investigation is needed.

New research suggests that when problem-solving, the brain can recognize when a strategy isn't working. In studying around 200 puzzle-takers with a computer model and functional MRI (fMRI) images, researchers have learned more about the processes of reasoning and decision-making, pinpointing the brain pathway that springs into action when problem-solving goes south.

In recent years, researchers have begun using functional magnetic resonance imaging (fMRI) not just for better understanding the neural bases of psychiatric illness, but also for experimental treatment of depression, ADHD, anxiety, PTSD, substance use disorder, and schizophrenia with a technique called real-time fMRI neurofeedback (rtfMRI-NF).

As the pandemic enters its second year, the case for optimism has grown shakier. SARS-CoV-2 has been mutating. New variants have arisen in the United Kingdom, Brazil and South Africa, and seem intent on evading our remarkable new vaccines before we’ve even fully rolled them out.

In this article, we discuss the potential benefits of Natural killer (NK) cell therapies.

Researchers are working tirelessly to design new drugs and repurpose existing drugs against the novel coronavirus SARS-CoV-2.

At Technology Networks we understand the importance of time. That's why we've launched Teach Me in 10 a video series that challenges scientists to present and summarize their research area, a scientific concept, or technology in ten minutes or less.

Technology Networks recently interviewed Prof. Mick Bhatia, from McMaster University, to learn more about his research focused on the role of abnormal dopamine receptor pathway activation in adult patients with acute myeloid leukemia (AML).

In this article, we discuss the evolution from today’s pharmaceutical manufacturing to the future methods of Pharma 4.0. In particular, we explore some of the technologies and techniques that can smooth that transition and briefly review several ongoing examples of industrial innovation.